ArticleJTO clinical and research reports2022

Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report.

Mariona Riudavets et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.